Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease

Affiliations

• ¹ Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA, 02215, USA. sfrank2@bidmc.harvard.edu.
• ² Georgetown University, Washington, DC, USA.
• ³ Cleveland Clinic, Cleveland, OH, USA.
• ⁴ University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, FL, USA.
• ⁵ Vanderbilt University Medical Center, Nashville, TN, USA.
• ⁶ Teva Branded Pharmaceutical Products R&D, Inc., La Jolla, CA, USA.
• ⁷ Emory University, Atlanta, GA, USA.
• ⁸ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁹ Teva Pharmaceutical Industries Ltd., Netanya, Israel.
• ¹⁰ Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
• ¹¹ Teva Pharmaceuticals International GmbH, Basel, Switzerland.